N-[(2R,4R,5R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]-N'-(2-methyl-3-oxotetradecan-4-yl)butanediamide

C31H56N2O13 — CID 59335275

IUPACN-[(2R,4R,5R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]-N'-(2-methyl-3-oxotetradecan-4-yl)butanediamide
SMILESCCCCCCCCCCC(NC(=O)CCC(=O)N[C@@H]1OC(CO)[C@H](O[C@@H]2OC(CO)[C@H](O)[C@H](O)C2O)[C@H](O)C1O)C(=O)C(C)C
InChIInChI=1S/C31H56N2O13/c1-4-5-6-7-8-9-10-11-12-18(23(38)17(2)3)32-21(36)13-14-22(37)33-30-27(42)26(41)29(20(16-35)44-30)46-31-28(43)25(40)24(39)19(15-34)45-31/h17-20,24-31,34-35,39-43H,4-16H2,1-3H3,(H,32,36)(H,33,37)/t18?,19?,20?,24-,25-,26+,27?,28?,29-,30+,31-/m0/s1
InChIKeySOWJNECDPQKZPU-YWCXNCQQSA-N
MW664.79 g/mol
LogP-1.25
Rot. Bonds20

About N-[(2R,4R,5R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]-N'-(2-methyl-3-oxotetradecan-4-yl)butanediamide

N-[(2R,4R,5R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]-N'-(2-methyl-3-oxotetradecan-4-yl)butanediamide (PubChem CID 59335275) has the molecular formula C31H56N2O13 and a molecular weight of 664.79 g/mol. Its IUPAC name is N-[(2R,4R,5R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]-N'-(2-methyl-3-oxotetradecan-4-yl)butanediamide.

Molecular Properties

Compound NameN-[(2R,4R,5R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]-N'-(2-methyl-3-oxotetradecan-4-yl)butanediamide
PubChem CID59335275
Molecular FormulaC31H56N2O13
Molecular Weight664.79 g/mol
Exact Mass664.38
IUPAC NameN-[(2R,4R,5R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]-N'-(2-methyl-3-oxotetradecan-4-yl)butanediamide
SMILESCCCCCCCCCCC(NC(=O)CCC(=O)N[C@@H]1OC(CO)[C@H](O[C@@H]2OC(CO)[C@H](O)[C@H](O)C2O)[C@H](O)C1O)C(=O)C(C)C
InChIInChI=1S/C31H56N2O13/c1-4-5-6-7-8-9-10-11-12-18(23(38)17(2)3)32-21(36)13-14-22(37)33-30-27(42)26(41)29(20(16-35)44-30)46-31-28(43)25(40)24(39)19(15-34)45-31/h17-20,24-31,34-35,39-43H,4-16H2,1-3H3,(H,32,36)(H,33,37)/t18?,19?,20?,24-,25-,26+,27?,28?,29-,30+,31-/m0/s1
InChIKeySOWJNECDPQKZPU-YWCXNCQQSA-N
XLogP-1.25
TPSA244.57 Ų
H-Bond Donors9
H-Bond Acceptors13
Rotatable Bonds20
Heavy Atoms46
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500664.79
LogP ≤ 5-1.25
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[(2R,4R,5R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]-N'-(2-methyl-3-oxotetradecan-4-yl)butanediamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(2R,4R,5R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]-N'-(2-methyl-3-oxotetradecan-4-yl)butanediamide?
The IUPAC name of N-[(2R,4R,5R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]-N'-(2-methyl-3-oxotetradecan-4-yl)butanediamide (CID 59335275) is N-[(2R,4R,5R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]-N'-(2-methyl-3-oxotetradecan-4-yl)butanediamide.
What is the SMILES notation for N-[(2R,4R,5R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]-N'-(2-methyl-3-oxotetradecan-4-yl)butanediamide?
The canonical SMILES for N-[(2R,4R,5R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]-N'-(2-methyl-3-oxotetradecan-4-yl)butanediamide is CCCCCCCCCCC(NC(=O)CCC(=O)N[C@@H]1OC(CO)[C@H](O[C@@H]2OC(CO)[C@H](O)[C@H](O)C2O)[C@H](O)C1O)C(=O)C(C)C.
What is the InChIKey of N-[(2R,4R,5R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]-N'-(2-methyl-3-oxotetradecan-4-yl)butanediamide?
The InChIKey is SOWJNECDPQKZPU-YWCXNCQQSA-N. The full InChI is InChI=1S/C31H56N2O13/c1-4-5-6-7-8-9-10-11-12-18(23(38)17(2)3)32-21(36)13-14-22(37)33-30-27(42)26(41)29(20(16-35)44-30)46-31-28(43)25(40)24(39)19(15-34)45-31/h17-20,24-31,34-35,39-43H,4-16H2,1-3H3,(H,32,36)(H,33,37)/t18?,19?,20?,24-,25-,26+,27?,28?,29-,30+,31-/m0/s1.
What are the key properties of N-[(2R,4R,5R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]-N'-(2-methyl-3-oxotetradecan-4-yl)butanediamide?
N-[(2R,4R,5R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]-N'-(2-methyl-3-oxotetradecan-4-yl)butanediamide has a molecular weight of 664.79 g/mol, XLogP of -1.25, 20 rotatable bonds, 9 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(2R,4R,5R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]-N'-(2-methyl-3-oxotetradecan-4-yl)butanediamide is sourced from PubChem (CID 59335275), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).